Investigation of serum substance P status in patients with chronic pruritic skin lesions due to sulfur mustard: a cross-sectional study
- PMID: 22681041
- DOI: 10.3109/15569527.2012.686077
Investigation of serum substance P status in patients with chronic pruritic skin lesions due to sulfur mustard: a cross-sectional study
Abstract
Purpose: Chronic cutaneous complications of sulfur mustard (SM) are quite common among intoxicated patients. Among these complications, pruritus represents the most frequent symptom which has significant influence on the quality of life (QoL). The present was undertaken to assess serum levels of substance P in patients who suffer from chronic pruritic lesions due to SM.
Methods: For this cross-sectional study, patients suffering from chronic SM-induced pruritic skin lesions (n = 40) and atopic dermatitis (AD)-induced pruritus (n = 20) were recruited. Healthy subjects (n = 10) with no dermatologic disorder were also recruited as control groups. Serum substance P was measured using an enzyme-linked immunosorbent assay. Pruritus severity was assessed using pruritus score and visual analogue scale (VAS). QoL was evaluated using the dermatology life quality index (DLQI).
Results: Significantly elevated serum concentrations of SP were found in the SM compared to the control (p < 0.001) and AD group (p < 0.001). Pruritus score was also higher in the SM compared to both control (p < 0.001) and AD groups (p < 0.001). While there was a higher VAS score in the SM vs. AD group (p = 0.019), no significant difference was observed for DLQI scores (p > 0.05). Significant correlations were found between serum SP and pruritus score in all assessed groups (p < 0.05).
Conclusion: In light of the present findings, elevated SP levels might be regarded as an important contributor of SM-induced chronic pruritus and a potential target for reducing the symptoms.
Similar articles
-
Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial.Br J Nutr. 2012 Oct;108(7):1272-9. doi: 10.1017/S0007114511006544. Epub 2011 Nov 18. Br J Nutr. 2012. PMID: 22099425 Clinical Trial.
-
Serum levels of interleukins 2, 4, 6, and 10 in veterans with chronic sulfur mustard-induced pruritus: a cross-sectional study.Skinmed. 2013 Jul-Aug;11(4):205-9. Skinmed. 2013. PMID: 24053005
-
Doxepin cream vs betamethasone cream for treatment of chronic skin lesions due to sulfur mustard.Skinmed. 2011 May-Jun;9(3):152-8. Skinmed. 2011. PMID: 21675494 Clinical Trial.
-
Management of sulfur mustard-induced chronic pruritus: a review of clinical trials.Cutan Ocul Toxicol. 2012 Sep;31(3):220-5. doi: 10.3109/15569527.2011.631655. Epub 2011 Nov 15. Cutan Ocul Toxicol. 2012. PMID: 22085409 Review.
-
Chronic pruritus associated with dermatologic disease in infancy and childhood: update from an interdisciplinary group of dermatologists and pediatricians.Pediatr Allergy Immunol. 2013 Sep;24(6):527-39. doi: 10.1111/pai.12115. Pediatr Allergy Immunol. 2013. PMID: 23980845 Review.
Cited by
-
Topical cyclosporine a for treatment of dry eye due to chronic mustard gas injury.J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):417-22. doi: 10.4103/2008-322X.150803. J Ophthalmic Vis Res. 2014. PMID: 25709764 Free PMC article.
-
Serum level of substance P in patients with lung injuries due to sulfur mustard.Adv Biomed Res. 2014 Jun 25;3:137. doi: 10.4103/2277-9175.135154. eCollection 2014. Adv Biomed Res. 2014. PMID: 25161984 Free PMC article.
-
Epidermal hydration and skin surface lipids in patients with long-term complications of sulfur mustard poisoning.J Res Med Sci. 2015 Jul;20(7):640-5. doi: 10.4103/1735-1995.166200. J Res Med Sci. 2015. PMID: 26622252 Free PMC article.
-
TRPA1 and CGRP antagonists counteract vesicant-induced skin injury and inflammation.Toxicol Lett. 2018 Sep 1;293:140-148. doi: 10.1016/j.toxlet.2018.03.007. Epub 2018 Mar 10. Toxicol Lett. 2018. PMID: 29535050 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical